Annexin Pharmaceuticals AB (publ)
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2018-05-03 | Annexin Pharmaceuticals AB (publ) | Anna Frostegård | Chief Scientific and Medical Officer | Subscription | 309 464 | 0,48 | SEK | 148 542,72 | 2018-04-29 |
| 2018-05-18 | Annexin Pharmaceuticals AB (publ) | Jamal El Mosleh | VD | Acquisition | 11 364 | 0 | SEK | 0 | 2018-03-18 |
| 2018-05-24 | Annexin Pharmaceuticals AB (publ) | Jamal El Mosleh | VD | Acquisition | 11 364 | 8,8 | SEK | 100 003,2 | 2018-05-23 |
| 2018-05-28 | Annexin Pharmaceuticals AB (publ) | Jamal El Mosleh | VD | Acquisition | 94 410 | 8,8 | SEK | 830 808 | 2018-05-24 |
| 2018-05-29 | Annexin Pharmaceuticals AB (publ) | Jamal El Mosleh | VD | Acquisition | 94 410 | 8,8 | SEK | 830 808 | 2018-05-28 |
| 2019-03-11 | Annexin Pharmaceuticals AB (publ) | Jamal El Mosleh | VD | Acquisition | 38 452 | 1,59 | SEK | 61 138,68 | 2019-03-10 |
| 2020-02-27 | Annexin Pharmaceuticals AB (publ) | Lena Torlegård | Styrelseledamot/suppleant | Acquisition | 50 000 | 1,258 | SEK | 62 894,95 | 2020-02-24 |
| 2020-02-27 | Annexin Pharmaceuticals AB (publ) | Lena Torlegård | Styrelseledamot/suppleant | Acquisition | 27 273 | 1,26 | SEK | 34 363,98 | 2020-02-24 |
| 2020-02-28 | Annexin Pharmaceuticals AB (publ) | Nils Anders Haegerstrand | VD | Acquisition | 45 500 | 1,25 | SEK | 56 875 | 2020-02-25 |
| 2020-02-28 | Annexin Pharmaceuticals AB (publ) | Nils Anders Haegerstrand | VD | Acquisition | 50 000 | 1,29 | SEK | 64 500 | 2020-02-25 |
| 2020-02-28 | Annexin Pharmaceuticals AB (publ) | Nils Anders Haegerstrand | VD | Acquisition | 50 000 | 1,29 | SEK | 64 500 | 2020-02-25 |